Keyphrases
National Cohort Study
100%
Chemotherapy-induced
100%
Dose Reduction
100%
Acute Myeloid Leukemia
100%
Overweight Patient
100%
Chemotherapy Dose
100%
Body Surface Area
14%
Restricted Mean Survival Time
14%
Confidence Interval
7%
Risk Factors
7%
No Significant Difference
7%
30-day Mortality
7%
High Body Mass Index
7%
Complete Remission
7%
Overall Survival
7%
90-day Mortality
7%
Patients with Cancer
7%
Median Overall Survival
7%
Overweight Adults
7%
Leukemia Patients
7%
Adult Acute Lymphoblastic Leukemia
7%
T-AML
7%
Relapse-free Survival
7%
Limited Samples
7%
Remission Induction
7%
Area-based
7%
Toxicity Issues
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Obesity
100%
Chemotherapy
100%
Acute Myeloid Leukemia
100%
Remission
33%
Overall Survival
33%
Survival Time
33%
Malignant Neoplasm
16%
Recurrence Free Survival
16%
Immunology and Microbiology
Drug Dose Reduction
100%
Myeloid
100%
Overall Survival
14%
Survival Time
14%
Surface Area
14%
Body Surface
14%
Body Mass
7%
Recurrence Free Survival
7%
Sample Size
7%